Related Experiment Video

Updated: Jun 20, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification

Anis Rassi1, Anis Rassi, José Antonio Marin-Neto

  • 1Anis Rassi Hospital, Goiânia, GO, Brasil. arassijr@terra.com.br

Memorias Do Instituto Oswaldo Cruz
|September 16, 2009
PubMed

Insights

Chagas heart disease (CHD), caused by Trypanosoma cruzi, leads to myocarditis and heart failure. Understanding its pathophysiology and risk factors is crucial for managing patient outcomes.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Parasitology

Background:

  • Chagas heart disease (CHD) is a major cause of infectious myocarditis globally, resulting from Trypanosoma cruzi infection.
  • It affects 20-40% of infected individuals 10-30 years post-infection, leading to significant morbidity and mortality.
  • Pathogenesis involves persistent parasitism, immune responses, neuronal damage, and microvascular dysfunction.

Purpose of the Study:

  • To review the pathophysiology of myocardial damage in CHD.
  • To discuss current risk stratification models for CHD.
  • To propose an algorithm for mortality risk assessment and therapeutic decision-making in CHD patients.

Main Methods:

  • Literature review of clinical and experimental investigations.
  • Analysis of existing risk stratification models.
  • Development of a proposed management algorithm.

Main Results:

  • Myocardial damage in CHD is driven by persistent parasitism and immune responses, with neuronal and microvascular factors playing ancillary roles.
  • Common clinical manifestations include arrhythmias, heart failure, thromboembolism, and sudden cardiac death.
  • Current risk stratification models aid in identifying patients at higher risk.

Conclusions:

  • Effective management of CHD requires symptom relief, prognosis assessment, and targeted treatment for high-risk individuals.
  • A structured approach to risk assessment and therapeutic decision-making is essential for improving patient outcomes in CHD.

More Related Videos

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model09:23

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model

Published on: July 29, 2012

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...